LithaBone TCP 300

LithaBone TCP 300 contains a beta-tricalcium phosphate (ß-TCP) based ceramic which in the right setting, enables implants with defined pore geometries. The material can be resorbed by the body and replaced by new bone.

Material Details

Tricalcium phosphate (TCP) is a material widely recognized for its excellent biocompatibility, bioresorbability, and osteoconductivity, making it highly suitable for bone replacement applications in regenerative medicine. These properties enable TCP to support bone regeneration and integration with the surrounding tissue.

The key characteristics of LithaBone TCP 300, which incorporates TCP powder, are as follows:

1. Biocompatibility: TCP exhibits excellent biocompatibility, meaning it is well-tolerated by the body and does not induce adverse reactions when used in medical applications. This property is crucial for materials intended for bone replacement, as it allows for proper integration and healing.
2. Bioresorbability: TCP is bioresorbable, which means it can be gradually absorbed by the body over time. This property enables the material to be gradually replaced by newly formed bone tissue during the healing process.
3. Osteoconductivity: TCP is osteoconductive, meaning it promotes the growth of new bone tissue. It provides a scaffold for bone cells to migrate and proliferate, facilitating bone regeneration.

LithaBone TCP 300 is manufactured using TCP powder that is ASTM F1088-04a certified. This certification ensures that the material meets the requirements for use in human implants, providing confidence in its suitability and safety for medical applications.

TCP, including LithaBone TCP 300, is non-cytotoxic according to the ISO 10993-5 standard. This standard assesses the potential cytotoxicity of materials used in medical devices to ensure they do not harm living cells. Additionally, the material is not irritating to the skin, as per the ISO 10993-10 standard.

Certifications for LithaBone TCP 300 are available upon request, providing further validation of its compliance with industry standards and regulations.

LithaBone TCP 300 is particularly well-suited for applications such as biological scaffolds, bone substitute implants, and similar uses where biocompatibility, bioresorbability, and osteoconductivity are important factors.

For precise information and certifications specific to LithaBone TCP 300, it is advisable to consult the manufacturer's documentation or contact the supplier directly.